FERRING
Company Snapshot
Company Overview
Ferring is a specialty biopharmaceutical group that offers products in the areas of reproductive medicine, women’s health, gastroenterology and urology. The company was established in 1950 as a privately owned company and is headquartered in Switzerland. It launched its U.S. operations in 1980. It offers reproductive medicine and maternal health and is expanding its operations across other therapeutic areas, including urology/uro-oncology. It operates its subsidiaries in over 50 countries and distributes its products in 100 countries. In 2024, the company introduced a new commercial structure with five geographical areas: U.S., WECAN (Western Europe and Canada), JAK (Japan, Australia, New Zealand and Korea), Intercontinental (the Rest of the World) and Greater China (China, Hong Kong and Taiwan).
FERRING In News
Company's Business Segments
- Reproductive Medicine & Maternal Health : This segment deals with fertility, safe birth, and preterm birth.
- Gastroenterology : This segment deals with Inflammatory bowel diseases (IBDs) and Clostridioides difficile infection.
- Urology & Uro-Oncology : This segment deals with Bladder cancer, prostate cancer, Bedwetting, and Nocturia.
Applications/End User Industries
- Healthcare
- Life Sciences
- Reproductive Medicine
- Maternal Health